Search by Drug Name or NDC

    NDC 69238-2548-03 Tasimelteon 20 mg/1 Details

    Tasimelteon 20 mg/1

    Tasimelteon is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals NY LLC. The primary component is TASIMELTEON.

    Product Information

    NDC 69238-2548
    Product ID 69238-2548_071804f4-9647-4a4d-a394-55b9e976dc9f
    Associated GPIs
    GCN Sequence Number 072007
    GCN Sequence Number Description tasimelteon CAPSULE 20 MG ORAL
    HIC3 H8B
    HIC3 Description HYPNOTICS, MELATONIN MT1/MT2 RECEPTOR AGONISTS
    GCN 36068
    HICL Sequence Number 040927
    HICL Sequence Number Description TASIMELTEON
    Brand/Generic Generic
    Proprietary Name Tasimelteon
    Proprietary Name Suffix n/a
    Non-Proprietary Name Tasimelteon
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 20
    Active Ingredient Units mg/1
    Substance Name TASIMELTEON
    Labeler Name Amneal Pharmaceuticals NY LLC
    Pharmaceutical Class Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA211654
    Listing Certified Through 2024-12-31

    Package

    NDC 69238-2548-03 (69238254803)

    NDC Package Code 69238-2548-3
    Billing NDC 69238254803
    Package 30 CAPSULE in 1 BOTTLE (69238-2548-3)
    Marketing Start Date 2023-02-24
    NDC Exclude Flag N
    Pricing Information N/A